EndoCor to Present at Medtech Insight and Windhover Information's ``Investment In Innovation (In3) WEST'' Conference, February 23-24, 2006, Irvine, CA.IRVINE, Calif. -- EndoCor has announced that it will be presenting on 23 February 2006 at 3:35 p.m. at Medtech Insight and Windhover wind·hov·er n. Chiefly British A kestrel. Information's "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" Conference, February 23-24, 2006, at the Hyatt Regency Irvine in Irvine, California. EndoCor will be showcasing its latest technology and is seeking to raise seed funding for ongoing research and development, intellectual property protection and the initiation of pre-clinical trials. EndoCor's first product is a minimally invasive aortic valve aortic valve n. The valve between the left ventricle of the heart and the ascending aorta, consisting of three semilunar cusps. Aortic valve implant aimed at the existing heart valve replacement Heart Valve Replacement Definition Heart valve replacement is a surgical procedure during which surgeons remove a damaged valve from the heart and substitute a healthy one. market. The technology consists of a diseased valve encapsulation device, self-expanding valve stent with pericardial pericardial /peri·car·di·al/ (-kahr´de-al) 1. pertaining to the pericardium. 2. surrounding the heart. pericardial pertaining to the pericardium. leaflets and a unique delivery system. It is designed to be implanted in a minimally invasive surgical procedure through the apex of the heart The apex of the heart is the lowest superficial part of the heart. It is directed downward, forward, and to the left, and is overlapped by the left lung and pleura. External anatomy It lies behind the fifth left intercostal space, 8 to 9 cm. without the need for cardiopulmonary bypass cardiopulmonary bypass n. A procedure to circulate and oxygenate the blood during heart surgery involving the diversion of blood from the heart and lungs through a heart-lung machine and the return of oxygenated blood to the aorta. . Key elements of the technology allows for secure anchoring, accurate valve repositioning and removal, prevention of paravalvular leaks and maintains leaflet integrity. EndoCor's minimally invasive aortic valve implant will be available in various sizes to match patient's needs. EndoCor's minimally invasive aortic valve implant will provide a drastically less traumatic surgery with shorter recovery time that translates into cost savings for the patient. Intellectual property protection has been initiated through the filing of a provisional US patent. Functional prototypes of the valve stent and delivery device are undergoing early testing. EndoCor was incorporated in September 2005 and is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. based in Singapore. An early stage start-up company start-up company A new business. , EndoCor was formed to develop, manufacture and market medical devices aimed at reducing the trauma of open-heart, valve surgeries. Its percutaneous aortic valve system is at the forefront of next generation valve implantation technology. For more information, e-mail info@endocor.com or visit the company's website at www.endocor.com. A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. In3 WEST is Medtech Insight's 20th investment and partnering event to date. To register to attend or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512 or 888-202-5939 toll-free in the U.S., e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion